Synovial Fluid Interleukin Levels Cannot Distinguish between Prosthetic Joint Infection and Active Rheumatoid Arthritis after Hip or Knee Arthroplasty.
Early prosthetic hip joint infection treated with debridement, prosthesis retention and biofilm-active antibiotics: functional outcomes, quality of life and complications.
Management of septic arthritis of the hip joint in adults. A systematic review of the literature.
Balato G, de Matteo V, Ascione T, de Giovanni R, Marano E, Rizzo M, Mariconda M.
BMC Musculoskelet Disord. 2021 Dec 2;22(Suppl 2):1006. doi: 10.1186/s12891-021-04843-z.
Comparison of Joint Mobilization and Movement Pattern Training for Patients With Hip-Related Groin Pain: A Pilot Randomized Clinical Trial.
Harris-Hayes M, Zorn P, Steger-May K, Burgess MM, DeMargel RD, Kuebler S, Clohisy J, Haroutounian S.
Phys Ther. 2023 Nov 4;103(11):pzad111. doi: 10.1093/ptj/pzad111.
Arthroplasties for hip fracture in adults.
Lewis SR, Macey R, Parker MJ, Cook JA, Griffin XL.
Cochrane Database Syst Rev. 2022 Feb 14;2(2):CD013410. doi: 10.1002/14651858.CD013410.pub2.
Treatment of Hip and Knee Periprosthetic Joint Infection Requires Extensive Administrative Work.
Mohler SA, Stambough JB, Mears SC, Kathiresan AR, Barnes CL, Stronach BM.
J Arthroplasty. 2024 Dec;39(12):2898-2903. doi: 10.1016/j.arth.2024.06.027. Epub 2024 Jun 17.
Rates and Outcomes of Periprosthetic Joint Infection in Persons Who Inject Drugs.
Humphrey TJ, Tatara AM, Bedair HS, Alpaugh K, Melnic CM, Nelson SB.
J Arthroplasty. 2023 Jan;38(1):152-157. doi: 10.1016/j.arth.2022.07.018. Epub 2022 Aug 3.
Mycobacterium avium complex prosthetic joint infection: A systematic review of the literature and pooled analysis.
Kim SJ, Lee DW, Lee C, Kim JH.
J Orthop Surg (Hong Kong). 2023 Sep-Dec;31(3):10225536231199392. doi: 10.1177/10225536231199392.
Phase 1 study of the pharmacokinetics and clinical proof-of-concept activity of a biofilm-disrupting human monoclonal antibody in patients with chronic prosthetic joint infection of the knee or hip.
Conway J, Delanois RE, Mont MA, Stavrakis A, McPherson E, Stolarski E, Incavo S, Oakes D, Salvagno R, Adams JS, Kisch-Hancock A, Tenorio E, Leighton A, Ryser S, Kauvar LM, Bernthal NM.
Antimicrob Agents Chemother. 2024 Aug 7;68(8):e0065524. doi: 10.1128/aac.00655-24. Epub 2024 Jul 16.
Estimation of two-year hospital costs of hip and knee periprosthetic joint infection treatments using activity-based costing.
Hammat AS, Nelson R, Davis JS, Manning L, Campbell D, Solomon LB, Gnanamanickam ES, Callary SA.
Bone Joint J. 2024 Oct 1;106-B(10):1084-1092. doi: 10.1302/0301-620X.106B10.BJJ-2024-0106.R1.
Serum biomarkers in the diagnosis of periprosthetic joint infection: consolidated evidence and recent developments.
Vicenti G, Bizzoca D, Nappi V, Pesce V, Solarino G, Carrozzo M, Moretti F, Dicuonzo F, Moretti B.
Eur Rev Med Pharmacol Sci. 2019 Apr;23(2 Suppl):43-50. doi: 10.26355/eurrev_201904_17473.
Bacteriophage therapy as an innovative strategy for the treatment of Periprosthetic Joint Infection: a systematic review.
Yang S, Mukh AA, Abdelatif E, Schmidt A, Batailler C, Ferry T, Lustig S.
Int Orthop. 2024 Nov;48(11):2809-2825. doi: 10.1007/s00264-024-06295-1. Epub 2024 Sep 10.
